XML 104 R66.htm IDEA: XBRL DOCUMENT v3.26.1
Notes Payable - 2025 March Unsecured SPA Notes Narrative (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
May 28, 2025
$ / shares
Mar. 21, 2025
USD ($)
day
closing
$ / shares
Mar. 31, 2026
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
shares
Dec. 31, 2025
USD ($)
$ / shares
Aug. 14, 2025
$ / shares
May 15, 2025
$ / shares
Dec. 31, 2024
USD ($)
Jul. 31, 2024
$ / shares
Debt Instrument [Line Items]                  
Exercise price (in dollars per share) | $ / shares                 $ 110,400
Class A Common Stock                  
Debt Instrument [Line Items]                  
Share price (in dollars per share) | $ / shares         $ 1.02 $ 3.00      
2025 March Unsecured SPA Notes                  
Debt Instrument [Line Items]                  
Debt instrument, term     5 years            
Percent of purchaser's conversion shares     100.00%            
Notes Payable                  
Debt Instrument [Line Items]                  
Notes and loans payable     $ 46,367 $ 24,674 $ 60,666     $ 49,488  
Gain (loss) on fair value adjustment of debts     $ (5,212) 21,780          
2025 March Unsecured SPA Notes                  
Debt Instrument [Line Items]                  
Aggregate principal amount   $ 41,000              
Debt instrument, number of closings | closing   4              
Debt instrument, term   5 years              
Contractual Interest Rates   10.00%              
Debt instrument, redemption price, percentage   10.00%              
Redemption price, percentage   25.00%              
Conversion price (in dollars per share) | $ / shares $ 1.22 $ 1.29              
Debt instrument, floor price (in dollars per share) | $ / shares     $ 1.048            
Debt instrument, SPA waiver, term             45 days    
Debt instrument, SPA waiver, deferral period             20 days    
Share price (in dollars per share) | $ / shares             $ 1.00    
Debt instrument, convertible, threshold percentage of stock price trigger 100.00%                
Debt instrument, exercisable, threshold percentage of stock price trigger 120.00%                
Exercise price (in dollars per share) | $ / shares $ 1.464                
2025 March Unsecured SPA Notes | Series B Preferred Stock                  
Debt Instrument [Line Items]                  
Pro rata aggregate cap (in shares) | shares     9,000,000            
2025 March Unsecured SPA Notes | Notes Payable                  
Debt Instrument [Line Items]                  
Debt instrument, term     5 years            
Contractual Interest Rates   18.00% 10.00%   10.00%        
Redemption price, percentage   8.00%              
Debt instrument, convertible, threshold consecutive trading days | day   5              
Notes and loans payable     $ 3,442 763 $ 2,108     $ 0  
Proceeds from debt, net of issuance costs     4,700 2,000          
Debt conversion, converted amount     $ 1,700 $ 0          
Shares issued from conversion (in shares) | shares     1,837,760 0          
Gain (loss) on extinguishment of debt     $ (1,300) $ 0          
Gain (loss) on fair value adjustment of debts     $ (87) $ 44